PCK2 and prostate carcinoma: Using published prostate cancer microarray datasets, we found a much higher PCK2 expression in metastatic prostate cancer samples compared to normal tissue or primary cancer tissue in two datasets (GDS1439 and GDS2524) (Figure 3D and 3E), indicating that PCK2 is highly expressed in aggressive prostate cancer.